The 2024 LMG Life Sciences Awards has named BELLUS Health’s US$2-billion sale to GSK as an Impact Deal of the Year (for the Americas).
LMG Life Sciences nominates key legal players in the life sciences industry and recognizes their most outstanding work in this field. We appreciate this recognition and thank our clients for entrusting us with their most important matters.
The Davies team that acted for BELLUS Health includes Sébastien Roy, Steven Cutler, Amélie Doyon, Ryan Brun and Noah Abitbol (Corporate and Public M&A); Brian Bloom and Taj Kudhail (Tax); Charles Tingley and Dajena Pechersky (Competition, Antitrust and Foreign Investment); Hélène Bussières (Employment, Labour and Executive Compensation); Louis-Martin O’Neill and Faiz Lalani (Dispute Resolution).
U.S. Supreme Court Upends 40 Years of Judicial Deference to Regulations
July 25, 2024 - In a historical opinion in Loper Bright Enterprises v. Raimondo, Secretary of Commerce, released at the end of June, the U.S. Supreme Court overturned the “Chevron” doctrine, which for so long had controlled judicial review of U.S. federal regulations. Chevron, decided in...
Is Canada Pulling the Plug on Chinese Electric Vehicles?
July 12, 2024 - Background The Canadian government has prioritized the promotion of the domestic electric vehicle (EV) industry, with the objective of establishing Canada as a leader in the global end-to-end EV supply chain. This effort includes providing financial support and tax credits to...
